Bessemer Group Portfolio holdings
AUM
$61.6B
1-Year Return
25.88%
This Quarter Return
-2.97%
1 Year Return
+25.88%
3 Year Return
+112.29%
5 Year Return
+188.53%
10 Year Return
+439.25%
AUM
$45.5B
AUM Growth
-$1.58B
(-3.4%)
Cap. Flow
+$389M
Cap. Flow
% of AUM
0.85%
Top 10 Holdings %
Top 10 Hldgs %
27.97%
Holding
2,416
New
128
Increased
815
Reduced
772
Closed
222
Top Buys
| 1 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$173M |
| 2 |
Jabil
JBL
|
$172M |
| 3 |
Halliburton
HAL
|
$117M |
| 4 |
Eli Lilly
LLY
|
$116M |
| 5 |
Meta Platforms (Facebook)
META
|
$98.7M |
Top Sells
| 1 |
Texas Instruments
TXN
|
$166M |
| 2 |
MGM Resorts International
MGM
|
$117M |
| 3 |
ConocoPhillips
COP
|
$86.6M |
| 4 |
AbbVie
ABBV
|
$75.1M |
| 5 |
Apple
AAPL
|
$73.7M |
Sector Composition
| 1 | Technology | 24.62% |
| 2 | Financials | 12.55% |
| 3 | Healthcare | 11.02% |
| 4 | Consumer Discretionary | 9.59% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
AngloGold Ashanti
AU
$30.2B
| $7.56M | 0.02% |
+478,145
| New | +$7.56M |
|
302
Texas Capital Bancshares
TCBI
$3.96B
| $7.54M | 0.02% |
128,068
+5,749
| +5% | +$339K |
|
303
IBM
IBM
$232B
| $7.48M | 0.02% |
53,334
+1,596
| +3% | +$224K |
|
304
MYR Group
MYRG
$2.79B
| $7.43M | 0.02% |
55,124
+13,665
| +33% | +$1.84M |
|
305
Pfizer
PFE
$141B
| $7.43M | 0.02% |
223,928
-14,069
| -6% | -$467K |
|
|
ENV
306
DELISTED
ENVESTNET, INC.
ENV
| $7.28M | 0.02% |
165,383
+7,326
| +5% | +$323K |
|
307
Kanzhun
BZ
$11.1B
| $7.28M | 0.02% |
479,845
-65,551
| -12% | -$994K |
|
308
AstraZeneca
AZN
$253B
| $7.28M | 0.02% |
107,414
-11,066
| -9% | -$749K |
|
309
iShares ESG Aware MSCI USA ETF
ESGU
$14.2B
| $7.27M | 0.02% |
77,464
| – | – |
|
310
Amgen
AMGN
$153B
| $7.26M | 0.02% |
27,003
+2,442
| +10% | +$656K |
|
311
Novo Nordisk
NVO
$245B
| $7.04M | 0.02% |
77,442
+4,096
| +6% | +$372K |
|
312
Idexx Laboratories
IDXX
$51.4B
| $7.03M | 0.02% |
16,070
+879
| +6% | +$384K |
|
|
AZEK
313
DELISTED
The AZEK Co
AZEK
| $6.98M | 0.02% |
234,554
+57,260
| +32% | +$1.7M |
|
314
FormFactor
FORM
$2.26B
| $6.94M | 0.02% |
198,621
+56,491
| +40% | +$1.97M |
|
315
Gilead Sciences
GILD
$143B
| $6.89M | 0.02% |
91,867
+26,381
| +40% | +$1.98M |
|
316
Fluor
FLR
$6.72B
| $6.87M | 0.02% |
187,186
+186,520
| +28,006% | +$6.84M |
|
317
Pinnacle Financial Partners
PNFP
$7.55B
| $6.82M | 0.02% |
101,693
-505
| -0.5% | -$33.8K |
|
318
Amphastar Pharmaceuticals
AMPH
$1.37B
| $6.81M | 0.02% |
148,144
+147,824
| +46,195% | +$6.8M |
|
319
P10
PX
$1.32B
| $6.8M | 0.01% |
583,785
+27,349
| +5% | +$319K |
|
320
Revolution Medicines
RVMD
$7.57B
| $6.74M | 0.01% |
243,442
-199,000
| -45% | -$5.51M |
|
321
Cigna
CI
$81.5B
| $6.72M | 0.01% |
23,476
-19
| -0.1% | -$5.44K |
|
322
CVB Financial
CVBF
$2.8B
| $6.67M | 0.01% |
402,537
+18,818
| +5% | +$312K |
|
323
Stevanato
STVN
$6.59B
| $6.66M | 0.01% |
223,994
-43,776
| -16% | -$1.3M |
|
324
Penske Automotive Group
PAG
$12.4B
| $6.39M | 0.01% |
38,245
+11,758
| +44% | +$1.96M |
|
325
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$54.8B
| $6.15M | 0.01% |
80,914
-23,902
| -23% | -$1.82M |
|